Proposed mechanisms of GLP-1RA-induced acute pancreatitis include pancreatic duct gland hyperplasia, pancreatic ductal obstruction leading to proinflammatory reactions, acinar cell hypertrophy, and pancreatic vascular injury.36 Additionally, another mechanism seen with the use of these drugs could be the increased risk of gallbladder or biliary diseases, especially when used in higher doses, for longer periods of time, and for weight loss.37 Previous animal studies suggested a risk of acute pancreatitis after GLP-1RA-based treatment.38 In addition, an initial analysis of the Food and Drug Administration's (FDA) adverse event reporting databases suggested an increased risk for acute pancreatitis with GLP-1RA-based therapy.39 It is important to note that this type of data analysis may not be the ideal method for comparing adverse event rates between medications
Semaglutide remains a common first GLP-1 path because coverage, familiarity, and prior response can make it the cleaner option
Related Article: Guide on How to use Sunscreen The skin-first movement is gaining popularity
Three consistent, nutrient-rich meals built around protein, fiber, and healthy fats
Explore peptide profiles, dosage calculators, and research tools at PeptidesExplorer